Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun

被引:211
作者
Meyer-ter-Vehn, T
Covacci, A
Kist, M
Pahl, HL
机构
[1] Univ Hosp Freiburg, Tumor Biol Ctr, Div Expt Anaesthesiol, D-79106 Freiburg, Germany
[2] IRIS, BIOCINE, I-53100 Siena, Italy
[3] Univ Freiburg, Inst Med Mikrobiol & Hyg, D-79104 Freiburg, Germany
关键词
D O I
10.1074/jbc.M000959200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Helicobacter pylori is an etiological agent in the development of mucosa-associated lymphoid tissue lymphoma and gastric adenocarcinoma. Patients infected with H. pylori carry a 3-6-fold increased risk of developing cancer compared with uninfected individuals. H. pylori strains expressing the cytotoxin-associated antigen A (CagA) are more frequently associated with the development of neoplasia than cagA-negative strains. However, the molecular mechanism by which H, pylori causes neoplastic transformation remains unclear. Here we report that exposure of gastric epithelial cells to H. pylori induces activation of the transcription factor activator protein 1, Activation of the proto-oncogenes c-fos and c-jun is strongly induced. We show that H. pylori activates the ERK/MAP kinase cascade, resulting in Elk-l phosphorylation and increased c-fos transcription. a. pylori strains that do not express CagA or that are mutated in cog genes encoded by the CagI pathogenicity island do not induce activator protein 1, MAP kinase activity, or c-fos or c-jun activation. Proto-oncogene activation may represent a crucial step in the pathomechanism of H. pylori induced neoplasia.
引用
收藏
页码:16064 / 16072
页数:9
相关论文
共 73 条
[41]   COLONY-STIMULATING FACTOR-I REGULATES NOVEL CYCLINS DURING THE G1 PHASE OF THE CELL-CYCLE [J].
MATSUSHIME, H ;
ROUSSEL, MF ;
ASHMUN, RA ;
SHERR, CJ .
CELL, 1991, 65 (04) :701-713
[42]  
MILLER AD, 1984, CELL, V36, P51
[43]   Regulation and function of the JNK subgroup of MAP kinases [J].
Minden, A ;
Karin, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1997, 1333 (02) :F85-F104
[44]  
Münzenmaier A, 1997, J IMMUNOL, V159, P6140
[45]  
Neugut AI, 1996, SEMIN ONCOL, V23, P281
[46]   HELICOBACTER-PYLORI INFECTION AND THE RISK FOR DUODENAL AND GASTRIC-ULCERATION [J].
NOMURA, A ;
STEMMERMANN, GN ;
CHYOU, PH ;
PEREZPEREZ, GI ;
BLASER, MJ .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) :977-981
[47]   Optimized BlaM-transposon shuttle mutagenesis of Helicobacter pylori allows the identification of novel genetic loci involved in bacterial virulence [J].
Odenbreit, S ;
Till, M ;
Haas, R .
MOLECULAR MICROBIOLOGY, 1996, 20 (02) :361-373
[48]   HELICOBACTER-PYLORI INFECTION AND THE RISK OF GASTRIC-CARCINOMA [J].
PARSONNET, J ;
FRIEDMAN, GD ;
VANDERSTEEN, DP ;
CHANG, Y ;
VOGELMAN, JH ;
ORENTREICH, N ;
SIBLEY, RK .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (16) :1127-1131
[49]   Helicobacter pylori cagA(+) strains and dissociation of gastric epithelial cell proliferation from apoptosis [J].
Peek, RM ;
Moss, SF ;
Tham, KT ;
PerezPerez, GI ;
Wang, SB ;
Miller, GG ;
Atherton, JC ;
Holt, PR ;
Blaser, MJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (12) :863-868
[50]  
PEEK RM, 1995, LAB INVEST, V71, P760